Invasive fungal disease: Conventional or molecular mycological diagnosis?;Enfermedad fúngica invasora: ¿diagnóstico micológico convencional o molecular?

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue 9, 2012, Pages 560-571

  Quindós, Guillermo ^a   Eraso, Elena ^a   López Soria, Leyre M ^b   Ezpeleta, Guillermo ^c  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL DE BASURTO   (Spain)

Author keywords

Anti germ tube antibodies; DNA; Fungaemia; Galactomannan; Invasive mycosis; Molecular diagnosis; Real time PCR; Traditional diagnosis; glucan

Indexed keywords

BETA GLUCAN; GALACTOMANNAN; NUCLEIC ACID;

ARTICLE; CLINICAL PRACTICE; DISEASE MARKER; FUNGUS ISOLATION; HUMAN; IMMUNOCOMPROMISED PATIENT; MOLECULAR DIAGNOSIS; SYSTEMIC MYCOSIS;

EID: 84868213176     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.10.018     Document Type: Review

References (123)

1. S. Ascioglu, J.H. Rex, P.B. De, J.E. Bennett, J. Bille, and F. Crokaert Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus Clin Infect Dis 34 2002 7 14 (Pubitemid 33152659)
2. B. De Pauw, T.J. Walsh, J.P. Donnelly, D.A. Stevens, J.E. Edwards, and T. Calandra Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813 1821
3. G. Quindós New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi Clin Microbiol Infect 12 Suppl 7 2006 40 52 (Pubitemid 44773207)
4. B.H. Segal Aspergillosis N Engl J Med 360 2009 1870 1884
5. O.A. Cornely, J. Maertens, M. Bresnik, R. Ebrahimi, E. Dellow, and R. Herbrecht Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease Mycoses 54 2011 e449 e455
6. C. Moran, C.A. Grussemeyer, J.R. Spalding, D.K. Benjamin Jr, and S.D. Reed Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections Am J Infect Control 38 2010 78 80
7. B.H. Segal, R. Herbrecht, D.A. Stevens, L. Ostrosky-Zeichner, J. Sobel, and C. Viscoli Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria Clin Infect Dis 47 2008 674 683
8. J. Ayats, E. Martín-Mazuelos, J. Pemán, G. Quindós, F. Sánchez, and J. García-Rodríguez Recomendaciones sobre el diagnóstico de la infección fúngica invasora de la Sociedad Española de Microbiología Clínica y Enfermedades Infecciosas (SEIMC). Actualización 2010 Enferm Infecc Microbiol Clin 29 2010 39.e1 39.e15
9. J. Maertens, K. Theunissen, G. Verhoef, J. Verschakelen, K. Lagrou, and E. Verbeken Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study Clin Infect Dis 41 2005 1242 1250 (Pubitemid 41534660)
10. N. Singh, B.D. Alexander, O. Lortholary, F. Dromer, K.L. Gupta, and G.T. John Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen Clin Infect Dis 46 2008 e12 e18
11. T. Avni, L. Leibovici, and M. Paul PCR diagnosis of invasive candidiasis: systematic review and meta-analysis J Clin Microbiol 49 2011 665 670
12. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2011; en prensa. (doi:10.1038/bmt.2011.178).
13. O. Bader, M. Weig, L. Taverne-Ghadwal, R. Lugert, U. Gross, and M. Kuhns Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry Clin Microbiol Infect 17 2011 1359 1365
14. A. Ferroni, S. Suarez, J.L. Beretti, B. Dauphin, E. Bille, and J. Meyer Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometry J Clin Microbiol 48 2010 1542 1548
15. R.M. Madej, J. Davis, M.J. Holden, S. Kwang, E. Labourier, and G.J. Schneider International standards and reference materials for quantitative molecular infectious disease testing J Mol Diagn 12 2010 133 143
16. C. Mengoli, M. Cruciani, R.A. Barnes, J. Loeffler, and J.P. Donnelly Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis Lancet Infect Dis 9 2009 89 96
17. J.M. Aguado, I. Ruiz, P. Muñoz, J. Mensa, B. Almirante, and L. Vázquez Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Española de Microbiología Clínica y Enfermedades Infecciosas (SEIMC). Actualización 2010 Enferm Infecc Microbiol Clin 29 2011 345 361
18. J. Fortún, J. Carratalá, J. Gavaldá, M. Lizasoain, M. Salavert, and R. De la Cámara Recomendaciones sobre el tratamiento de la infección fúngica invasiva por Aspergillus spp y otros hongos filamentosos de la Sociedad Española de Microbiología Clínica y Enfermedades Infecciosas (SEIMC). Actualización 2010 Enferm Infecc Microbiol Clin 29 2011 435 454
19. J.R. Perfect, W.E. Dismukes, F. Dromer, D.L. Goldman, J.R. Graybill, and R.J. Hamill Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America Clin Infect Dis 50 2010 291 322
20. T.J. Walsh, E.J. Anaissie, D.W. Denning, R. Herbrecht, D.P. Kontoyiannis, and K.A. Marr Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America Clin Infect Dis 46 2008 327 360 (Pubitemid 351265310)
21. G. Quindós, M.D. Moragues, and J. Pontón Is there a role for antibody testing in the diagnosis of invasive candidiasis? Rev Iberoam Micol 21 2004 10 14 (Pubitemid 39061973)
22. C. Lass-Flörl Zygomycosis: conventional laboratory diagnosis Clin Microbiol Infect 15 Suppl 5 2009 60 65
23. E.J. Calderon, S. Gutierrez-Rivero, I. Durand-Joly, and E. Dei-Cas Pneumocystis infection in humans: diagnosis and treatment Expert Rev Anti Infect Ther 8 2010 683 701
24. E. Mayayo, C. Klock, L.Z. Goldani, A.C. Monteiro, and J. Capilla Infección múltiple fúngica en un paciente diabético Rev Iberoam Micol 27 2010 140 143
25. E. Mayayo, J. Landeyro, A.M. Stchigel, A. Gazzoni, and J. Capilla Infiltración perineural por células fúngicas. Presentación de un caso y revisión de la literatura Rev Iberoam Micol 27 2010 94 97
26. Y. Oz, and N. Kiraz Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods Expert Rev Anti Infect Ther 9 2011 289 298
27. O. Cabaret, G. Toussain, N. Abermil, I.A. Alsamad, F. Botterel, and J.M. Costa Degradation of fungal DNA in formalin-fixed paraffin-embedded sinus fungal balls hampers reliable sequence-based identification of fungi Med Mycol 49 2011 329 332
28. E. Dannaoui, P. Schwarz, M. Slany, J. Loeffler, A.T. Jorde, and M. Cuenca-Estrella Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation J Clin Microbiol 48 2010 2043 2046
29. V. Hofman, A. Dhouibi, C. Butori, B. Padovani, M. Gari-Toussaint, and D. Garcia-Hermoso Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient Diagn Pathol 5 2010 1
30. V. Rickerts, P.D. Khot, D. Myerson, D.L. Ko, E. Lambrecht, and D.N. Fredricks Comparison of quantitative real time PCR with sequencing and ribosomal RNA-FISH for the identification of fungi in formalin fixed, paraffin-embedded tissue specimens BMC Infect Dis 11 2011 202
31. V. Rickerts, S. Mousset, E. Lambrecht, K. Tintelnot, R. Schwerdtfeger, and E. Presterl Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens Clin Infect Dis 44 2007 1078 1083 (Pubitemid 46580276)
32. A. Abad, J.V. Fernández-Molina, J. Bikandi, A. Ramirez, J. Margareto, and J. Sendino What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis Rev Iberoam Micol 27 2010 155 182
33. E. Alvarez, A.M. Stchigel, J. Cano, D.A. Sutton, A.W. Fothergill, and J. Chander Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: Proposal of three new species Rev Iberoam Micol 27 2010 80 89
34. L. Baires-Várguez, A. Cruz-García, L. Villa-Tanaka, S. Sánchez-García, L.A. Gaitán-Cepeda, and L.O. Sánchez-Vargas Comparison of a randomly amplified polymorphic DNA (RAPD) analysis and ATB ID 32 C system for identification of clinical isolates of different Candida species Rev Iberoam Micol 24 2007 148 151 (Pubitemid 47025152)
35. A. Cassone, F. De Bernardis, E. Pontieri, G. Carruba, C. Girmenia, and P. Martino Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity J Infect Dis 171 1995 967 975
36. J. Dong, M.J. Loeffelholz, and M.R. McGinnis Sequence-based fungal identification and classification Curr Infect Dis Rep 12 2010 430 436
37. D. Garcia-Hermoso, D.M. MacCallum, T.J. Lott, P. Sampaio, M.J. Serna, and F. Grenouillet Multicenter collaborative study for standardization of Candida albicans genotyping using a polymorphic microsatellite marker J Clin Microbiol 48 2010 2578 2581
38. M. Healy, K. Reece, D. Walton, J. Huong, K. Shah, and D.P. Kontoyiannis Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR J Clin Microbiol 42 2004 4016 4024 (Pubitemid 39296118)
39. A. Rementeria, L. Gallego, G. Quindós, and J. Garaizar Comparative evaluation of three commercial software packages for analysis of DNA polymorphism patterns Clin Microbiol Infect 7 2001 331 336 (Pubitemid 34966130)
40. R. San Millán, G. Quindós, J. Garaizar, R. Salesa, J. Guarro, and J. Pontón Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis J Clin Microbiol 35 1997 2270 2274 (Pubitemid 27349794)
41. R. San Millán, L. Ribacoba, J. Pontón, and G. Quindós Evaluation of a commercial medium for identification of Candida species Eur J Clin Microbiol Infect Dis 15 1996 153 158
42. E. Eraso, M.D. Moragues, M. Villar-Vidal, I.H. Sahand, N. Gónzalez-Gómez, and J. Pontón Evaluation of the new chromogenic medium Candida ID 2 for isolation and identification of Candida albicans and other medically important Candida species J Clin Microbiol 44 2006 3340 3345 (Pubitemid 44413774)
43. I.H. Sahand, M.D. Moragues, E. Eraso, M. Villar-Vidal, G. Quindós, and J. Pontón Supplementation of CHROMagar Candida medium with Pal's medium for rapid identification of Candida dubliniensis J Clin Microbiol 43 2005 5768 5770 (Pubitemid 41612359)
44. J. Gómez, E. García-Vázquez, C. Espinosa, J. Ruiz, M. Canteras, and A. Hernández-Torres Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005) Rev Iberoam Micol 26 2009 184 188
45. J.M. Molina, J. Córdoba, P. Ramírez, and M. Gobernado Detección automática de bacterias y hongos en sangre Enferm Infecc Microbiol Clin 26 Suppl 9 2008 75 80
46. J. Pemán, and R. Zaragoza Current diagnostic approaches to invasive candidiasis in critical care settings Mycoses 53 2010 424 433
47. P.P. Bosshard Incubation of fungal cultures: how long is long enough? Mycoses 54 2011 e539 e545
48. M.H. Miceli, J.A. Diaz, and S.A. Lee Emerging opportunistic yeast infections Lancet Infect Dis 11 2011 142 151
49. G. Quindós San Millán R, Robert R, Bernard C, Ponton J. Evaluation of bichro-latex albicans, a new method for rapid identification of Candida albicans J Clin Microbiol 35 1997 1263 1265 (Pubitemid 27175265)
50. I.H. Sahand, M.D. Moragues, R. Robert, G. Quindós, and J. Pontón Evaluation of Bichro-Dubli Fumouze to distinguish Candida dubliniensis from Candida albicans Diagn Microbiol Infect Dis 55 2006 165 167 (Pubitemid 43792406)
51. A.M. Freydiere, L. Buchaille, R. Guinet, and Y. Gille Evaluation of latex reagents for rapid identification of Candida albicans and C. krusei colonies J Clin Microbiol 35 1997 877 880 (Pubitemid 27146529)
52. J. Pemán, N. Aparisi, C. García-Esteban, and M. Gobernado Utilidad de una nueva técnica comercial, GLABRATA RTT, para la identificación rápida de Candida glabrata Rev Iberoam Micol 21 2004 82 84 (Pubitemid 39656221)
53. A.M. Borman, C.J. Linton, D. Oliver, M.D. Palmer, A. Szekely, and F.C. Odds Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis J Clin Microbiol 47 2009 2307 2310
54. D. Campa, A. Tavanti, F. Gemignani, C.S. Mogavero, I. Bellini, and F. Bottari DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses J Clin Microbiol 46 2008 909 915 (Pubitemid 351379978)
55. D. Hansen, M. Healy, K. Reece, C. Smith, and G.L. Woods Repetitive-sequence-based PCR using the DiversiLab system for identification of Aspergillus species J Clin Microbiol 46 2008 1835 1839 (Pubitemid 351657237)
56. M.E. Reller, A.B. Mallonee, N.P. Kwiatkowski, and W.G. Merz Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species J Clin Microbiol 45 2007 3802 3803 (Pubitemid 350156889)
57. O. Romeo, F. Scordino, I. Pernice, P.C. Lo, and G. Criseo A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis J Microbiol Methods 79 2009 117 120
58. P. Wang Rapid differentiation of Candida albicans from non-C. albicans directly in a variety of clinical specimens using fluorescent in situ hybridisation Mycoses 54 2011 331 336
59. P.L. White, A. Shetty, and R.A. Barnes Detection of seven Candida species using the Light-Cycler system J Med Microbiol 52 2003 229 238 (Pubitemid 36324210)
60. M.G. Wise, M. Healy, K. Reece, R. Smith, D. Walton, and W. Dutch Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCR J Med Microbiol 56 2007 778 787 (Pubitemid 46911233)
61. Clinical Laboratory Standards Institute Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; Approved Guideline 2008 Clinical Laboratory Standards Institute CLSI Document MM18 - A. Wayne, PA
62. J. Alcoba-Flórez, S. Méndez-Álvarez, J. Cano, J. Guarro, E. Pérez-Roth, and M.P. Árevalo Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus J Clin Microbiol 43 2005 4107 4111
63. R. Alonso-Vargas, L. Elorduy, E. Eraso, F.J. Cano, J. Guarro, and J. Pontón Isolation of Candida africana, probable atypical strains of Candida albicans, from a patient with vaginitis Med Mycol 46 2008 167 170 (Pubitemid 351372336)
64. J.A. Bishop, N. Chase, S.S. Magill, C.P. Kurtzman, M.J. Fiandaca, and W.G. Merz Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection J Clin Microbiol 46 2008 443 446 (Pubitemid 351231284)
65. A. Correia, P. Sampaio, S. James, and C. Pais Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata Int J Syst Evol Microbiol 56 2006 313 317 (Pubitemid 43125932)
66. A. Tavanti, A.D. Davidson, N.A. Gow, M.C. Maiden, and F.C. Odds Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III J Clin Microbiol 43 2005 284 292 (Pubitemid 40096313)
67. A. Alastruey-Izquierdo, M. Cuenca-Estrella, A. Monzon, and J.L. Rodriguez-Tudela Prevalence and susceptibility testing of new species of Pseudallescheria and Scedosporium in a collection of clinical mold isolates Antimicrob Agents Chemother 51 2007 748 751 (Pubitemid 46185300)
68. L. Alcazar-Fuoli, E. Mellado, A. Alastruey-Izquierdo, M. Cuenca-Estrella, and J.L. Rodriguez-Tudela Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification Antimicrob Agents Chemother 52 2008 1244 1251 (Pubitemid 351521983)
69. I. Miranda-Zapico, E. Eraso, J.L. Hernández-Almaraz, L.M. López-Soria, A.J. Carrillo-Muñoz, and J.M. Hernández-Molina Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital J Antimicrob Chemother 66 2011 2315 2322
70. F. Lamoth, K. Jaton, G. Prod'hom, L. Senn, J. Bille, and T. Calandra Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia J Clin Microbiol 48 2010 3510 3516
71. A. Lau, T.C. Sorrell, S. Chen, K. Stanley, J. Iredell, and C. Halliday Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens J Clin Microbiol 46 2008 3021 3027
72. A. Lau, C. Halliday, S.C. Chen, E.G. Playford, K. Stanley, and T.C. Sorrell Comparison of whole blood, serum, and plasma for early detection of candidemia by multiplex-tandem PCR J Clin Microbiol 48 2010 811 816
73. J.R. Shepard, R.M. Addison, B.D. Alexander, P. Della-Latta, M. Gherna, and G. Haase Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles J Clin Microbiol 46 2008 50 55
74. J. Trnovsky, W. Merz, P. Della-Latta, F. Wu, M.C. Arendrup, and H. Stender Rapid and accurate identification of Candida albicans isolates by use of PNA FISHFlow J Clin Microbiol 46 2008 1537 1540 (Pubitemid 351563612)
75. G. Quindós, J. Pontón, and R. Cisterna Detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidiasis Eur J Clin Microbiol 6 1987 142 146 (Pubitemid 17066106)
76. G. Quindós, J. Pontón, R. Cisterna, and D.W. Mackenzie Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis Eur J Clin Microbiol Infect Dis 9 1990 178 183 (Pubitemid 20105713)
77. A. Laín, M.D. Moragues, J.C. Ruiz, J. Mendoza, A. Camacho, and A. Del Palacio Evaluation of a novel enzyme-linked immunosorbent assay to detect immunoglobulin G antibody to enolase for serodiagnosis of invasive candidiasis Clin Vaccine Immunol 14 2007 318 319 (Pubitemid 46570291)
78. A. Laín, N. Elguezabal, E. Amutio, I. Fernandez de Larrinoa, M.D. Moragues, and J. Pontón Use of recombinant antigens for the diagnosis of invasive candidiasis Clin Dev Immunol 2008 2008 721950
79. J. Pemán, R. Zaragoza, G. Quindós, M. Alkorta, M.S. Cuétara, and J.J. Camarena Clinical factors associated with a Candida albicans germ tube antibody positive test in Intensive Care Unit patients BMC Infect Dis 11 2011 60
80. R. Zaragoza, J. Pemán, G. Quindós, J.R. Iruretagoyena, M.S. Cuétara, and P. Ramírez Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality Clin Vaccine Immunol 16 2009 1527 1528
81. R. Zaragoza, J. Pemán, G. Quindós, J.R. Iruretagoyena, M.S. Cuétara, and P. Ramírez Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients Clin Microbiol Infect 15 2009 592 595
82. C. Pazos, M.D. Moragues, G. Quindós, J. Pontón, and P.A. Del Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients Rev Iberoam Micol 23 2006 209 215 (Pubitemid 44735884)
83. J. Pontón Utilidad de los marcadores biológicos en el diagnóstico de la candidiasis invasora Rev Iberoam Micol 26 2009 8 14
84. A. Laín, N. Elguezabal, M.D. Moragues, J.C. García-Ruiz, P.A. Del, and J. Pontón Contribution of serum biomarkers to the diagnosis of invasive candidiasis Expert Rev Mol Diagn 8 2008 315 325 (Pubitemid 351724710)
85. C.D. Pfeiffer, J.P. Fine, and N. Safdar Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis Clin Infect Dis 42 2006 1417 1427
86. M.M. Leeflang, Y.J. Debets-Ossenkopp, C.E. Visser, R.J. Scholten, L. Hooft, and H.A. Bijlmer Galactomannan detection for invasive aspergillosis in immunocompromized patients Cochrane Database Syst Rev 2008 CD007394
87. J. Maertens, K. Buve, K. Theunissen, W. Meersseman, E. Verbeken, and G. Verhoef Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients Cancer 115 2009 355 362
88. C. Pazos, J. Pontón, and A. Del Palacio Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan J Clin Microbiol 43 2005 299 305 (Pubitemid 40096315)
89. S. Husain, D.L. Paterson, S.M. Studer, M. Crespo, J. Pilewski, and M. Durkin Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients Transplantation 83 2007 1330 1336 (Pubitemid 46800308)
90. S. Husain, C.J. Clancy, M.H. Nguyen, S. Swartzentruber, H. Leather, and A.M. LeMonte Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid Clin Vaccine Immunol 15 2008 1760 1763
91. J. Fortún, P. Martín-Dávila, M.E. Alvarez, F. Norman, A. Sánchez-Sousa, and L. Gajate False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients Transplantation 87 2009 256 260
92. S. Koo, J.M. Bryar, J.H. Page, L.R. Baden, and F.M. Marty Diagnostic performance of the (1- > 3)-beta-D-glucan assay for invasive fungal disease Clin Infect Dis 49 2009 1650 1659
93. Z. Racil, I. Kocmanova, M. Lengerova, B. Weinbergerova, L. Buresova, and M. Toskova Difficulties in using 1,3-beta-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis J Med Microbiol 59 2010 1016 1022
94. D.E. Karageorgopoulos, E.K. Vouloumanou, F. Ntziora, A. Michalopoulos, P.I. Rafailidis, and M.E. Falagas Beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis Clin Infect Dis 52 2011 750 770
95. S. Bretagne Molecular detection and characterization of fungal pathogens D.H. Persing, Molecular Microbiology: Diagnostic Principles and Practice 2011 ASM Press Washington 655 667
96. Cuenca-Estrella M, Bassetti M, Lass-Florl C, Racil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011; 66 (Supl. 1): i15-i24.
97. S. Preuner, and T. Lion Towards molecular diagnostics of invasive fungal infections Expert Rev Mol Diagn 9 2009 397 401
98. European Aspergillus PCR initiative. International Society of Human and Animal Mycology (ISHAM). [consultado 25 Sep 2011]. Disponible en: http://www.eapcri.eu/
99. P.L. White, R. Barton, M. Guiver, C.J. Linton, S. Wilson, and M. Smith A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections J Mol Diagn 8 2006 376 384 (Pubitemid 44063816)
100. P.L. White, M.D. Perry, J. Loeffler, W. Melchers, L. Klingspor, and S. Bretagne Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens J Clin Microbiol 48 2010 3753 3755
101. P.L. White, S. Bretagne, L. Klingspor, W.J. Melchers, E. McCulloch, and B. Schulz Aspergillus PCR: one step closer to standardization J Clin Microbiol 48 2010 1231 1240
102. Clinical Laboratory Standards Institute Proficiency testing (External Quality Assessment) for molecular methods; Approved Guideline 2005 Clinical Laboratory Standards Institute CLSI Document MM14 - A. Wayne, PA
103. Clinical Laboratory Standards Institute Collection, transport, preparation, and storage of specimens for molecular methods; Approved Guideline 2005 Clinical Laboratory Standards Institute CLSI Document MM13 - A. Wayne, PA
104. Clinical Laboratory Standards Institute Molecular diagnostic methods for infectious diseases; Approved Guideline - Second Edition 2006 Clinical Laboratory Standards Institute CLSI Document MM3 - A2. Wayne, PA
105. Clinical Laboratory Standards Institute Quantitative molecular methods for infectious diseases; Approved Guideline - Second Edition 2010 Clinical Laboratory Standards Institute CLSI Document MM6 - A2. Wayne, PA
106. Clinical Laboratory Standards Institute Verification and validation of multiplex nucleic acid assays; Approved Guideline 2008 Clinical Laboratory Standards Institute CLSI Document MM17 - A. Wayne, PA
107. S. Bretagne Primary diagnostic approaches of invasive aspergillosis - molecular testing Med Mycol 49 Suppl 1 2011 S48 S53
108. S. Bretagne Advances and prospects for molecular diagnostics of fungal infections Curr Infect Dis Rep 12 2010 430 436
109. M.J. Holden, R.M. Madej, P. Minor, and L.V. Kalman Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testing Expert Rev Mol Diagn 11 2011 741 755
110. E. Frealle, K. Decrucq, F. Botterel, B. Bouchindhomme, D. Camus, and E. Dei-Cas Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance Eur J Clin Microbiol Infect Dis 28 2009 223 232
111. I. Hadrich, C. Mary, F. Makni, M. Elloumi, H. Dumon, and A. Ayadi Comparison of PCR-ELISA and Real-Time PCR for invasive aspergillosis diagnosis in patients with hematological malignancies Med Mycol 49 2011 489 494
112. Ministerio de Sanidad y Consumo Real Decreto 1662/2000, de 29 de septiembre, sobre productos sanitarios para diagnóstico in vitro BOE 235 2000 33482 33508
113. Ministerio de Sanidad y Consumo Real Decreto 1143/2007, de 31 de agosto, por el que se modifican los Reales Decretos 634/1993, de 3 de mayo, sobre productos sanitarios implantables activos; 414/1996, de 1 de marzo, por el que se regula los productos sanitarios; y 1662/2000, de 29 de septiembre, sobre productos sanitarios para diagnóstico in vitro BOE 210 2007 36289 36296
114. Parlamento Europeo y Consejo de la Unión Europea Directiva 98/79/CE del Parlamento Europeo y del Consejo de 27 de octubre de 1998 sobre productos sanitarios para diagnóstico in vitro Diario Oficial de la Comunidades Europeas L331 1998 1 36
115. D. Bravo, J. Blanquer, M. Tormo, G. Aguilar, R. Borras, and C. Solano Diagnostic accuracy and potential clinical value of the LightCycler SeptiFast assay in the management of bloodstream infections occurring in neutropenic and critically ill patients Int J Infect Dis 15 2011 e326 e331
116. J.C. Palomares, S. Bernal, M. Marin, V.P. Holgado, C. Castro, and W.P. Morales Molecular diagnosis of Aspergillus fumigatus endocarditis Diagn Microbiol Infect Dis 70 2011 534 537
117. J. Steinmann, J. Buer, P.M. Rath, A. Paul, and F. Saner Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast Transpl Infect Dis 11 2009 175 178
118. M. von Lilienfeld-Toal, L.E. Lehmann, A.D. Raadts, C. Hahn-Ast, K.S. Orlopp, and G. Marklein Utility of a commercially available multiplex real-time PCR assay to detect bacterial and fungal pathogens in febrile neutropenia J Clin Microbiol 47 2009 2405 2410
119. F. Wallet, S. Nseir, L. Baumann, S. Herwegh, B. Sendid, and M. Boulo Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood Clin Microbiol Infect 16 2010 774 779
120. S.H. Armenian, K.A. Nash, N. Kapoor, J.L. Franklin, P.S. Gaynon, and L.A. Ross Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients J Pediatr Hematol Oncol 31 2009 920 926
121. R. Sherif, and B.H. Segal Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications Curr Opin Pulm Med 16 2010 242 250
122. S. Koo, J.M. Bryar, L.R. Baden, and F.M. Marty Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis J Clin Microbiol 48 2010 1255 1260
123. Z. Racil, I. Kocmanova, M. Lengerova, J. Winterova, and J. Mayer Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum J Clin Microbiol 45 2007 3141 3142 (Pubitemid 47417379)